Fig. 6

Effect of ASMDM, trimethoprim, and B. cenocepacia on KP1 viability. Phage viability was measured in the wells that contained phage. At 0 and every 24 h for 72 h, a plaque assay was performed to determine PFU/ml. A) PAS treatment with high dose of trimethoprim (0.88 mg/well). N = 4. B) Treatment with low dose of trimethoprim (0.0088 mg/well). N = 3. Values are mean ± standard deviation. MOI = 17. PAS treatment (circle), KP1 phage alone (square). Statistical analysis was performed with MANOVA, P < .05. There were no significant differences